CIDRAP newsletters options
In 2022, only 440 cases (1.5%) were recorded in rural areas.
Protection against ICU admission and death was 69% 1 week to 2 months after a bivalent dose and 50% at 4 to 6 months.
In other updates, the WHO's latest epi report notes transmission and new cases in some world regions, including parts of Asia and in Pakistan.
Hospitalizations for COVID-19 are down 11% compared to a week ago, and deaths from the virus are down 13.3%.
From 2020 to early 2022 in England, the COVID-19 infection-fatality ratio decreased from 0.67% to 0.10%.
Delayed diagnoses of lung, breast, and colorectal cancers will likely be on the rise because of missed cancer screenings during the pandemic.
Removing urinalysis and urine cultures from preoperative checklists for cardiac surgery was linked to a significant decrease in antibiotic prescriptions.
A team of researchers has discovered, with the help of AI, a new antibiotic with the potential to fight a multidrug-resistant pathogen.
The number of suspected or probable fungal meningitis infections tied to contaminated spinal anesthesia products from Mexico has risen to 18 in the US.
Leading the list of symptoms are post-exertion malaise, fatigue, brain fog, dizziness, GI symptoms, heart palpitations, and changes in sexual desire.
In another COVID development, the FDA today announced full approval for the use of Paxlovid in adults at risk for more severe disease.
A 5-valent vaccine would target more strains of the bacteria and could be another tool in the arsenal to reduce disease burden in Africa.
Data suggest an increased risk of new-onset mental illness only in SARS-CoV-2–positive patients aged 70 and older.
Experts from the Annenberg Public Policy Center prefer "Vaccination Safety Monitor" or "Vaccination Safety Watch" over VAERS.
Opening of the NBAF in Kansas marks the culmination of an effort since 2006 to replace the 68-year-old Plum Island Animal Disease Facility in New York.
An assessment of 16 randomized clinical trials suggests shorter antibiotic durations are as safe and effective as longer durations in children with community-acquired pneumonia.
An analysis conducted at Mayo Clinic sites found that female clinicians were no less likely than male clinicians to have stewardship recommendations accepted.
Particulate matter, nitrous oxide, and black carbon exposures were all associated with severe outcomes.
Maternal death occurred more often in patients who had cardiac arrest, acute kidney injury, or intracranial hemorrhage (brain bleed).
Xacduro targets infections caused by Acinetobacter baumannii, which currently have limited treatment options.
